Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment

Speciality: Oncology


Speaker:

Dr. Poonam Patil | Senior Consultant - Medical Oncology

Description:

A warm welcome to all the medical professionals in this crucial session on understanding the Current Cancer Scenario in India. The landscape of cancer care in India is rapidly evolving, with a growing emphasis on personalized medicine. The integration of genomic testing has become increasingly important, moving beyond a one-size-fits-all approach to diagnosis and treatment. Recent advancements in technology and a better understanding of cancer biology are enabling healthcare providers to identify specific genetic mutations that drive tumor growth, leading to more targeted and effective therapies.

In a country as diverse as India, with a unique genetic makeup across its population, the importance of genomic testing is paramount. It allows for the identification of hereditary cancer syndromes, a more accurate prognosis, and the selection of therapies that are most likely to work for an individual patient. This is particularly relevant as India grapples with a rising cancer burden, where traditional treatments may not always be the most effective. Genomic testing, therefore, provides a roadmap for clinicians to navigate the complexities of cancer, offering a new level of precision and hope for better patient outcomes.

Therefore, get a deep understanding of the current cancer scenario in India and the transformative role of genomic testing and advanced diagnostics. Listen to this insightful discussion by Dr. Poonam Patil, grab the shared knowledge on the latest advancements in diagnosis and treatment, and follow Hidoc for more such indispensable webinar sessions.

See More Webinars @ Hidoc Webinars





Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Nearly 6 Million Deaths From Five Major Cancer Types Averted Since 1975

2.

Child Death Rates Are Rising in the U. s. ; Water Beads Warning; Cancer Studies Retracted.

3.

Interleukin-6 may boost prediction of obesity-related cancers

4.

Researchers use AI to monitor side effects of chemotherapy and support families dealing with pediatric cancer.

5.

As EGFR internalization is decreased, BUB1 controls EGFR signaling.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot